We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
As 2021 kicked off with the first-ever virtual J.P. Morgan, HealthXL collaborated with BrightInsight to bring together global leaders from across healthcare, medtech and life sciences to a Digital Health C-Suite meeting series. No long flights, no jet lags, no overpriced hotel rooms and coffees, but the same great minds to connect and brainstorm with. Over three days, we dove into hot topics in Digital Health. Here are our key takeaways!
These industries are lightyears ahead of Biopharma in their digital transformation. Who better to bring together for valuable insights on challenges overcome than leaders with experience from Amazon, MGM, Venmo and Volvo? Atif Rafiq, President, Commercial & Growth, MGM Resorts and Former Chief Digital Officer, Volvo, and Amit Jhawar, Former CEO, Venmo and Venture Partner, Accel led the conversation.
What we shared:
We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.
If Medtech’s digitization journey is a marathon, we’ve only just passed the first mile-marker. Medtech is finally evolving past traditional medical devices (think pacemakers) to connected devices that collect and share data.. So, what can Medtech do to activate this data to achieve meaningful outcomes? Scott Huennekens, Medical Device CEO, Entrepreneur, Chairman, Board Member and Mick Farrell CEO, ResMed led the conversation.
What we shared:
We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.
Biopharma is dabbling with technology and they need the right leadership and teams to really build and grow these functions that have not been their bread and butter to date. There is also a realization that investing heavily in only R&D is showing diminishing returns. So what steps can Biopharma take to build a strategic digital health function amongst all this change? Kal Patel, MD, CEO & Co-Founder, BrightInsight was joined by Karan Arora, Chief Commercial Digital Officer, Global Vice President, AstraZeneca and Francesca Wuttke, Chief Digital Officer, Almirall to led the conversation.
What we shared:
Want to join our community? We’d love to hear from you!
About HealthXL and BrightInsight:
BrightInsight accelerates the speed at which biopharma and medtech companies can build and commercialise regulated digital health solutions through its regulated digital health platform.
HealthXL connects global leaders on common digital health challenges.
Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.
Are you a HealthXL Member? See the Full Report Here
Non-HealthXL Member? You can purchase the report HERE
Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
Digital health technologies enable strategic touchpoints with patients and healthcare practitioners, and generate a wealth of real world data. Pharmaceutical companies and their medical affairs teams are yet to fully tap into the potential and opportunities of technology powered patient journeys.
The buzz surrounding AI's role in healthcare is undeniable. Yet, amidst these discussions, a key question remains: Where should AI be harnessed to truly optimize return-on-investment (ROI)?
In the modern healthcare landscape, the importance of leveraging data-driven insights to enhance patient experiences cannot be overstated. Pharmaceutical companies need to connect with patients because it can bring about big changes in how healthcare is provided
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
.png)
